What are 2 FDA approved vaccines of cancer?

Provenge (Sipuleucel-T): — Customized treatment of metastatic prostate cancer — Approved in 2010 — Life expectation prolonged for 4 months Imlygic (talimogen laherparepvec: T-VEC) — Treatment of recurrent melanoma after surgery — Approved in October 2015 — Oncolytic virus therapy